Hiroshi Yamagata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroshi Yamagata has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Kensuke Satomoto
Ishihara Sangyo Kaisha, Ltd., 3-1 Nishi-shibukawa 2-chome, Kusatsu, Shiga 525-0034, Japan
2 shared publications - Makoto Shibutani
Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo, 183-8509, Japan.
2 shared publications - Ryoko Harada
ITR Laboratories Canada Inc., 19601 Clark Graham Ave, Quebec, Baie-D'Urfé H9X 3T1, Canada
2 shared publications - Ryota Ojiro
Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo, 183-8509, Japan; Cooperative Division of Veterinary Sciences, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo, 183-8509, Japan
2 shared publications - Shuichi Hamada
BoZo Res Ctr Inc, Tokyo Lab, 1-3-11 Hanegi,Setagaya Ku, Tokyo 1560042, Japan
2 shared publications - Tomoya Yoshinari
Division of Microbiology, National Institute of Health Sciences
2 shared publications
Latest Publications
- 17 March 2026
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 911, 503930
Hepatocyte proliferation assessed by proliferating cell nuclear antigen (PCNA) in relation to age and chemical exposure: Comparison with Ki-67 and mitotic index in the liver micronucleus assay
- 17 March 2026
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 911, 503930
Hepatocyte proliferation assessed by proliferating cell nuclear antigen (PCNA) in relation to age and chemical exposure: Comparison with Ki-67 and mitotic index in the liver micronucleus assay
- Open Access
- 19 February 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 199, 115336
Emerging mycotoxin moniliformin induces renal tubular necrosis after oral exposure in mice
- 19 February 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 199, 115336
Open AccessEmerging mycotoxin moniliformin induces renal tubular necrosis after oral exposure in mice
- 16 September 2024
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 899, 503825
The effect of aging on the repeated-dose liver micronucleus assay using N-nitrosodipropylamine, quinoline, and carbendazim
- 16 September 2024
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 899, 503825
The effect of aging on the repeated-dose liver micronucleus assay using N-nitrosodipropylamine, quinoline, and carbendazim
- Open Access
- 11 May 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 177, 113814
Pharmacokinetics and 28-day repeated-dose toxicity of enniatin B after oral administration in mice
- 11 May 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 177, 113814
Open AccessPharmacokinetics and 28-day repeated-dose toxicity of enniatin B after oral administration in mice
- Open Access
- 18 August 2022
- Published by Springer Nature in Genes and Environment
- Vol. 44 (1) , 1-7
The effect of aging on the repeated-dose liver micronucleus assay using diethylnitrosamine
Background: The repeated-dose liver micronucleus (RDLMN) assay has been well-developed and applied because of its simplicity and the ease of integration into general toxicity studies which is the preferred method from the 3R’s point of view. In this assay, we observed micronucleated hepatocytes which accumulated during a rather long-term dosing period. When considering integration into general toxicity studies, the effects of age of the animals used in the micronucleus assay becomes a major issue. The effect of age on the micronucleus induction rate has been reported in bone marrow micronucleus assays, and it is considered that the decrease in cell proliferation rate due to aging is the cause of the decrease in sensitivity. A decrease in sensitivity due to aging was also reported in a liver micronucleus assay using clofibrate and the cause is considered to be a decrease in hepatocyte proliferation activity due to aging. However, no actual decrease in hepatocyte proliferation rate due to aging has been reported. In addition, there are no reports, so far, on whether similar effects of aging appear when other substances were administered. To investigate the effects of aging in the RDLMN assay, this study focused on the effects of 14-day repeated administration of DEN, a well-known genotoxic hepatocarcinogen with the hepatocyte toxicity which should cause an elevation of cell proliferation rate as a reflective regeneration.Results: The liver micronuclei induced by DEN were equivalent between the two age groups (i.e., six and eight weeks of age at the start of dosing). In the histopathological examination for the liver, single cell necrosis, karyomegaly, and increased mitosis were observed in the hepatocytes, and the frequency and severity were increased dose-dependently. Ki-67 immunohistochemical analysis which can detect all cells in the cell cycle other than those in the G0 phase revealed dose-dependent increase of cell proliferation activity, and the difference between ages was not observed.Conclusion: The effect of aging on the RDLMN assay could not be recognized when DEN was administered for 14 days in rats. Meanwhile, it was supported by the histopathological examination and Ki-67 immunohistochemical analysis that such an effect of aging was masked by the compensatory hepatocyte proliferation which was induced by the hepatocyte toxicity of DEN.
- 18 August 2022
- Published by Springer Nature in Genes and Environment
- Vol. 44 (1) , 1-7
Open AccessThe effect of aging on the repeated-dose liver micronucleus assay using diethylnitrosamine
Background: The repeated-dose liver micronucleus (RDLMN) assay has been well-developed and applied because of its simplicity and the ease of integration into general toxicity studies which is the preferred method from the 3R’s point of view. In this assay, we observed micronucleated hepatocytes which accumulated during a rather long-term dosing period. When considering integration into general toxicity studies, the effects of age of the animals used in the micronucleus assay becomes a major issue. The effect of age on the micronucleus induction rate has been reported in bone marrow micronucleus assays, and it is considered that the decrease in cell proliferation rate due to aging is the cause of the decrease in sensitivity. A decrease in sensitivity due to aging was also reported in a liver micronucleus assay using clofibrate and the cause is considered to be a decrease in hepatocyte proliferation activity due to aging. However, no actual decrease in hepatocyte proliferation rate due to aging has been reported. In addition, there are no reports, so far, on whether similar effects of aging appear when other substances were administered. To investigate the effects of aging in the RDLMN assay, this study focused on the effects of 14-day repeated administration of DEN, a well-known genotoxic hepatocarcinogen with the hepatocyte toxicity which should cause an elevation of cell proliferation rate as a reflective regeneration.Results: The liver micronuclei induced by DEN were equivalent between the two age groups (i.e., six and eight weeks of age at the start of dosing). In the histopathological examination for the liver, single cell necrosis, karyomegaly, and increased mitosis were observed in the hepatocytes, and the frequency and severity were increased dose-dependently. Ki-67 immunohistochemical analysis which can detect all cells in the cell cycle other than those in the G0 phase revealed dose-dependent increase of cell proliferation activity, and the difference between ages was not observed.Conclusion: The effect of aging on the RDLMN assay could not be recognized when DEN was administered for 14 days in rats. Meanwhile, it was supported by the histopathological examination and Ki-67 immunohistochemical analysis that such an effect of aging was masked by the compensatory hepatocyte proliferation which was induced by the hepatocyte toxicity of DEN.
- Open Access
- 1 August 2022
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 35 (4) , 313-320
Lack of hepatocarcinogenicity of 2,2’-[1,2-ethanediylbis(oxymethylene)]bis-oxirane, 3-hydroxy-2-naphthoic acid, and acetoacetanilide in a medium-term rat liver bioassay
The carcinogenicity of 2,2'-[1,2-ethanediylbis(oxymethylene)]bis-oxirane (ethylene glycol diglycidyl ether; EGDE), 3-hydroxy-2-naphthoic acid (HNA), and acetoacetanilide (AAA) was investigated using a medium-term rat liver bioassay for an occupational safety assessment. F344 male rats were administered a single intraperitoneal injection of diethylnitrosamine (200 mg/kg body weight (bw)/day) and then starting 2 weeks later, they received EGDE at 6, 20, and 60 mg/kg bw/day, HNA at 20, 60, and 200 mg/kg bw/day, or AAA at 60, 200, and 600 mg/kg bw/day by oral gavage for 6 weeks. The animals in the positive control group received phenobarbital sodium solution (PB, 25 mg/kg bw/day) by oral gavage and those in the negative control group received a vehicle (water/corn oil) during the administration period of test substances in this model. All animals were subjected to two-thirds partial hepatectomy at week 3 and euthanized at week 8. Neither the number nor the area of hepatocellular foci positive for glutathione S-transferase placental form (GST-P) increased in any of the EGDE, HNA, or AAA treated groups. However, the number and area of GST-P-positive foci significantly increased in the positive control group treated with PB. The results indicate that EGDE, HNA, and AAA lack hepatocarcinogenicity in rats.
- 1 August 2022
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 35 (4) , 313-320
Open AccessLack of hepatocarcinogenicity of 2,2’-[1,2-ethanediylbis(oxymethylene)]bis-oxirane, 3-hydroxy-2-naphthoic acid, and acetoacetanilide in a medium-term rat liver bioassay
The carcinogenicity of 2,2'-[1,2-ethanediylbis(oxymethylene)]bis-oxirane (ethylene glycol diglycidyl ether; EGDE), 3-hydroxy-2-naphthoic acid (HNA), and acetoacetanilide (AAA) was investigated using a medium-term rat liver bioassay for an occupational safety assessment. F344 male rats were administered a single intraperitoneal injection of diethylnitrosamine (200 mg/kg body weight (bw)/day) and then starting 2 weeks later, they received EGDE at 6, 20, and 60 mg/kg bw/day, HNA at 20, 60, and 200 mg/kg bw/day, or AAA at 60, 200, and 600 mg/kg bw/day by oral gavage for 6 weeks. The animals in the positive control group received phenobarbital sodium solution (PB, 25 mg/kg bw/day) by oral gavage and those in the negative control group received a vehicle (water/corn oil) during the administration period of test substances in this model. All animals were subjected to two-thirds partial hepatectomy at week 3 and euthanized at week 8. Neither the number nor the area of hepatocellular foci positive for glutathione S-transferase placental form (GST-P) increased in any of the EGDE, HNA, or AAA treated groups. However, the number and area of GST-P-positive foci significantly increased in the positive control group treated with PB. The results indicate that EGDE, HNA, and AAA lack hepatocarcinogenicity in rats.
- Open Access
- 15 May 2022
- Published by Japan Society for Clinical Anesthesia in THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
- Vol. 42 (3) , 222-226
A Case of Hip Pain Due to Hip Osteoarthrosis Which was Diagnosed by PENG(Pericapsular Nerve Group)Block during the Treatment of L5 Radioculopathy Due to Degenerative Lumbar Scoliosis
Pericapsular nerve group(PENG)ブロックは,前股関節包に分布する神経をターゲットとしている.大腿骨骨折の術後鎮痛として有用だが,股関節由来の痛みの診断にも有用であった症例を経験した.症例は70歳代女性.腰椎変性側弯症に伴う腰下肢痛に対して腰部神経根ブロックとパルス高周波法を施行し,右腰下肢痛は一旦軽減した.しかし,経過観察中に新たに右股関節周囲の痛みが出現した.右変形性股関節症による疼痛を疑い,診断目的にPENGブロックを施行したところ,疼痛軽減を認めた.PENGブロックの効果から腰下肢痛の原因には股関節の病変も関与していたと診断し得た.
- 15 May 2022
- Published by Japan Society for Clinical Anesthesia in THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
- Vol. 42 (3) , 222-226
Open AccessA Case of Hip Pain Due to Hip Osteoarthrosis Which was Diagnosed by PENG(Pericapsular Nerve Group)Block during the Treatment of L5 Radioculopathy Due to Degenerative Lumbar Scoliosis
Pericapsular nerve group(PENG)ブロックは,前股関節包に分布する神経をターゲットとしている.大腿骨骨折の術後鎮痛として有用だが,股関節由来の痛みの診断にも有用であった症例を経験した.症例は70歳代女性.腰椎変性側弯症に伴う腰下肢痛に対して腰部神経根ブロックとパルス高周波法を施行し,右腰下肢痛は一旦軽減した.しかし,経過観察中に新たに右股関節周囲の痛みが出現した.右変形性股関節症による疼痛を疑い,診断目的にPENGブロックを施行したところ,疼痛軽減を認めた.PENGブロックの効果から腰下肢痛の原因には股関節の病変も関与していたと診断し得た.